e-Nose how to sniff the good from the bad
Alpha M.O.S. has recently released an update for its Fox electronic nose (e-Nose) to provide faster analytical analysis of samples in R&D, quality control (QC) and process monitoring settings.
Archives for April 25, 2007
Paladin Labs buys into film technology with BioEnvelop deal
Paladin Labs has reached an agreement in principle to acquire the outstanding shares of BioEnvelop Inc, which develops, manufactures and markets rapidly dissolving edible films for use as delivery systems in the pharmaceutical and nutraceutical sectors.
Solvay files arrhythmia drug for approval
Solvay Pharmaceuticals has filed a niche drug to treat irregular heart beats with US and European regulators.
Owens-Illinois seals healthcare plastics joint venture in Mexico
Owens-Illinois, the US company best known as a manufacturer of glass containers, has finalised a 50/50 joint venture with Pavisa Industries to manufacture and sell plastic healthcare containers in Mexico and other Latin markets.
Priming immune system cells
New research suggests that it may be possible to design a vaccine that will enable the immune system to 'remember' pathogens without a preceding strong immune response.
Parexel healthy in Q3 despite weak med comm business
Parexel has announced healthy financial results for its third fiscal quarter, despite another disappointing performance in its medical communications business.
Roche updates on flu manufacturing; expands US unit
Roche gave an update on its manufacturing of influenza drug Tamiflu (oseltamivir) today, saying that while it had reached its target capacity of 400 million doses a year, demand is running much lower.
OctoPlus broadens rights to PolyActive delivery technology
Dutch company OctoPlus has extended its rights to the PolyActive delivery technology used in its lead drug candidate Locteron, based on interferon alfa.
Covance ranks New England Peptide first in quality test
A US-based peptide provider, New England Peptide, has ranked first in a recent peptide quality validation study conducted by Covance.